A delay in deliveries from India and the need to retest a batch of 1.7 million doses is behind an expected shortfall in coronavirus vaccine supply in April, Matt Hancock has said.The Health Secretary told MPs that a partnership with the Serum Institute of India is one the UK “can be proud of”, despite a delay in deliveries of the AstraZeneca vaccine from its plant.
